Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver diseaseKazumichi Abe, Hiromasa Ohira, Atsushi Takahashi et al.|PLoS ONE|2018Cited by 116
Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinomaMasashi Fujita, Hiromasa Ohira, Atsushi Takahashi et al.|Hepatology Research|2019Cited by 59
Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver DiseaseAtsushi Takahashi, Hiromasa Ohira, Kazumichi Abe et al.|International Journal of Sports Medicine|2015Cited by 52
Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement PathwayManabu Hayashi, Hideharu Sekine, Takeshi Machida et al.|The Journal of Immunology|2019Cited by 50
Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosisKazumichi Abe, Hiromasa Ohira, Masashi Fujita et al.|PLoS ONE|2020Cited by 45